Mantle cell lymphoma

Haematologica

Volumn 94, Issue 11, 2009, Pages 1488-1492

  Pileri, Stefano A ^a   Falini, Brunangelo ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; LYMPHOCYTE ANTIGEN RECEPTOR;

CANCER IMMUNOTHERAPY; CHROMOSOME TRANSLOCATION; DISEASE CLASSIFICATION; EDITORIAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TRANSLOCATION; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTOMA; MANTLE CELL LYMPHOMA; PROGNOSIS;

GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA, MANTLE-CELL; PROGNOSIS;

EID: 70449380278     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.013359     Document Type: Editorial

References (24)

1. Weisenburger DD, Kim H, Rappaport H. Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma. Cancer 1982;49:1429-1438
2. Swerdlow SH, Habeshaw JA, Murray LJ, Dhaliwal HS, Lister TA, Stansfeld AG. Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse. Am J Pathol 1983;113:181-197
3. Lennert K. Malignant lymphomas other than Hodgkin's disease. New York: Springer-Verlag; 1978.
4. Pileri S, Rivano MT, Gobbi M, Taruscio D, Lennert K. Neoplastic and reactive follicles within B-cell malignant lymphomas. A morphological and immunological study of 30 cases. Hematol Oncol 1985;3:243-260
5. Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, et al. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992;16:637-640
6. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392 (Pubitemid 24273002)
7. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC, 2008.
8. Quintanilla-Martinez L, Slotta-Huspenina J, Koch I, Klier M, His ED, de Leval L, et al. Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-polymerase chain reaction. Haematologica 2009;94:1595-1598
9. Mozos A, Royo C, Hartmann E, DeJong S, Baró C, Valera A, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1 negative subtype. Haematologica 2009;94:1555-1562
10. Dictor M, Ek S, Sundberg M, Warenholt J, György C, Sernbo S, et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica 2009;94:1563-1568
11. Ghielmini M, Zucca E. How I treat mantle cell lymphoma. Blood 2009;114:1469-1476
12. Jares P, Campo E. Advances in the understanding of mantle cell lymphoma. Br J Haematol 2008;142:149-165 (Pubitemid 351994053)
13. Pileri SA, Ascani S, Sabattini E, Fraternali-Orcioni G, Poggi S, Piccioli M, et al. The pathologist's view point. Part I-indolent lymphomas. Haematologica 2000;85:1291-1307
14. Young KH, Chan WC, Fu K, Iqbal J, Sanger WG, Ratashak A, et al. Mantle cell lymphoma with plasma cell differentiation. Am J Surg Pathol 2006;30:954-961 (Pubitemid 44264943)
15. Richard P, Vassallo J, Valmary S, Missoury R, Delsol G, Brousset P. "In situ-like" mantle cell lymphoma: a report of two cases. J Clin Pathol 2006;59:995-996
16. Falini B, Tiacci E, Pucciarini A, Bigerna B, Kurth J, Hatzivassiliou G, et al. Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). Blood 2003;102:3684-3692 (Pubitemid 37409389)
17. Went P, Ascani S, Strom E, Brorson SH, Musso M, Zinzani PL, et al. Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease. Lancet Oncol 2004;5:381-383 (Pubitemid 38684410)
18. Salaverria I, Zettl A, Bea S, Moreno V, Valls J, Hartmann E, et al. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol 2007;25:1216-1222 (Pubitemid 46640567)
19. Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003;3:185-197 (Pubitemid 37443390)
20. Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 2005;106:4315-4321 (Pubitemid 41775942)
21. Tiemann M, Schrader C, Klapper W, Dreyling MH, Campo E, Norton A, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 2005;131:29-38. (Pubitemid 43899705)
22. Determann O, Hoster E, Ott G, Wolfram Bernd H, Loddenkemper C, Leo Hansmann M, et al. Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group. Blood 2008;111:2385-2387
23. Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 2008;111:558-565
24. Hartmann E, Fernandez V, Moreno V, Valls J, Hernandez L, Bosch F, et al. Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue. J Clin Oncol 2008;26:4966-4972